Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.

Announcements

94

Total raised

£1.7B

disclosed amounts

Seed
£2.1M

The round was led by Blackfinch Ventures with participation from Praetura Ventures and the British Robotics Fund.

"Interest in intelligent chat solutions has exploded, as more organisations realise that this is accessible platform technology they can deploy instantly which completely changes how they deliver customer service. It is testament to our progress as a business and the appetite from our customers that we’re welcoming Blackfinch as an investor, along with increased support from Praetura and the British Robotics Fund."
— Andy Wilkins, CEO
Seed
£3.5M

Octopus Ventures leads a £3.5m seed round in Touchlab to advance robotic electronic skin technology.

"Touch is the final frontier for robot interaction and entry into physical environments – enabling true dexterity and safety. We have taken on this challenge by developing a ‘full-stack’ solution; retrofittable e-skin that gathers the data, software to make sense of it, and integration to ensure it works in demanding applications – from grocery grasping to telerobotics in extreme environments. Octopus’ expertise propel us to achieve e-skin’s full potential and create a step-change in robotics."
— Zaki Hussein, Founder and CEO
Series B
£36.7M

The investment round was led by Octopus Ventures with participation from multiple returning and strategic backers.

"Automata’s robotic capabilities are truly the first of its kind and the company has combined this with deep expertise in automation and a highly effective business model which has created a leading-edge over competitors. Automata Labs accelerates human ingenuity, empowering labs, and scientists, to achieve consistent results faster, on a greater scale, and to ultimately upscale their ambitions. We are delighted to have led this financing round as Automata represented exactly the type of highly innovative company we invest in and support. We are excited for Automata’s next steps, both within the life sciences industry, and beyond."
— Jess McCreadie, Principal, Healthtech